Creating an E-Business System Report

profiledj1200mk3
isysweek1assignment2.docx

For this first Assignment, you have the opportunity to exercise your evaluative skills. You will conduct research on e-business systems of existing companies and then select the company for which you will create an e-business system report for your Final Paper. Please make your selection after analyzing the requirements of the Final Project and evaluating the information available on the current IT infrastructure of existing companies.

By Day 7

Submit a 300- to 350-word explanation of why you selected the company you chose for your Final Paper. Explain each reason in detail.

Note: Refer to the Assignment Template in the Learning Resources.

Submission and Grading Information

To submit your completed Assignment for review and grading, do the following:

· Please save your Assignment using the naming convention “WK1Assgn+last name+first initial.(extension)” as the name.

· Click the Week 1 Assignment Rubric to review the Grading Criteria for the Assignment.

· Click the Week 1 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.

· Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK1Assgn+last name+first initial.(extension)” and click Open.

· If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.

· Click on the Submit button to complete your submission.

********************************************************************************************

The company I selected is Allergan PLC, a 60 year old large pharmaceutical company that has been my employer for the last 4 years. We develop, manufacture, market and distribute specialty pharmaceutical drugs and devices that are centered around 7 therapeutic areas. I specifically work within the Chief Medical Office which is known in the industry as the Medical Affairs organization. The organization was built in response to increased demands by the company to focus on new drugs while the company still needing to scientifically support post approved drugs. We are a global in nature with over 200 people based in the United States.

One of main functions is to maintain relationships with Healthcare Providers . We have a field based team of PharmD, MD and PhD’s that are called Medical Science Liaisons. One of the tools they use is called Veeva CRM. Veeva CRM is an application that sits within the Salesforce.com cloud and allows the MSLs to track their interactions with the HCPs

Another function within the CMO is to provide Medical Information. We provide dosing, usage, safety and efficacy information around our products, especially when new products are launched

Lastly, we support a variety of Phase IV, Educational, Publication and other Research Grants. Some of these teams are responsible for making sure that key scientific data is published around big conferences.

One of the issues we have is connecting all the data together. When an HCP requests study information, it goes to the Medical Information department. If the HCP asks for an MSL to visit him, we capture that request in another system. We have been working for a few years to get the data together but have had many challenges including a merger of 2 $60 billion companies, selling of the whole generics business and acquiring numerous companies valued over $1 billion.

Smith, P., & Crowley-Nowick, P. (2013). The Role of Medical Affairs in Moving from R&D to Commercialization - BioProcess International. BioProcess International. Retrieved 3 September 2017, from http://www.bioprocessintl.com/analytical/qa-qc/the-role-of-medical-affairs-in-moving-from-randd-to-commercialization-341871/